Market Cap ₹514 Cr.
Stock P/E 120.4
P/B 0.5
Current Price ₹894.9
Book Value ₹ 1835.3
Face Value 10
52W High ₹2415
Dividend Yield 0.11%
52W Low ₹ 801
National Peroxide Ltd is a producer of compressed hydrogen gas, hydrogen peroxide, sodium perborate, and per acetic acid. The Company operates via two divisions: production of peroxygens and hydrogen gas, and others, which consists of investing activities. It manufactures hydrogen peroxide with an capacity of 95,000 metric tons per annum (MTPA) on 50% weight per weight (w/w). Basis and in about 4 special forms, which consist of 50% w/w (Concentrated), 60% w/w (Concentrated), 35% w/w (Concentrated) and 70% w/w (Distillate). The Company's included production website for hydrogen peroxide is positioned at Kalyan in Maharashtra (India). The Company's subsidiary is Naperol Investments Ltd.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
Net Sales | 69 | 77 | 66 | 70 | 99 | 0 | 1 | 0 |
Other Income | 1 | 2 | 3 | 3 | 3 | 0 | 0 | 0 |
Total Income | 71 | 79 | 69 | 72 | 102 | 0 | 1 | 0 |
Total Expenditure | 53 | 49 | 38 | 38 | 41 | 0 | 0 | 1 |
Operating Profit | 18 | 29 | 31 | 34 | 61 | -0 | 1 | -1 |
Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 |
Exceptional Income / Expenses | -8 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 8 | 27 | 29 | 32 | 58 | -0 | 1 | -1 |
Provision for Tax | 2 | 9 | 10 | 11 | 21 | -0 | 0 | -0 |
Profit After Tax | 5 | 18 | 19 | 21 | 37 | -0 | 1 | -1 |
Adjustments | -5 | -18 | -19 | -21 | -37 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 1 | -1 |
Adjusted Earnings Per Share | 9 | 31.2 | 33.3 | 36.1 | 64.9 | -0 | 0.9 | -1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 212 | 235 | 196 | 234 | 232 | 306 | 402 | 191 | 214 | 0 | 2 | 100 |
Other Income | 5 | 6 | 6 | 8 | 6 | 10 | 19 | 18 | 13 | 0 | 0 | 3 |
Total Income | 217 | 241 | 203 | 242 | 238 | 316 | 421 | 209 | 227 | 0 | 2 | 103 |
Total Expenditure | 146 | 174 | 174 | 198 | 163 | 161 | 175 | 166 | 170 | 3 | 2 | 42 |
Operating Profit | 72 | 67 | 28 | 44 | 76 | 155 | 245 | 43 | 57 | -3 | -0 | 61 |
Interest | 0 | 0 | 5 | 5 | 2 | 1 | 1 | 3 | 13 | 0 | 0 | 0 |
Depreciation | 11 | 10 | 7 | 9 | 9 | 9 | 9 | 11 | 17 | 0 | 0 | 2 |
Exceptional Income / Expenses | 0 | 1 | 0 | -1 | -8 | 1 | 0 | 0 | -15 | 5 | 376 | 0 |
Profit Before Tax | 60 | 58 | 16 | 29 | 57 | 146 | 235 | 29 | 12 | 2 | 376 | 58 |
Provision for Tax | 21 | 20 | 10 | 11 | 19 | 51 | 82 | 12 | -9 | 1 | 1 | 21 |
Profit After Tax | 40 | 39 | 6 | 18 | 38 | 95 | 153 | 17 | 21 | 1 | 375 | 37 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | -37 |
Profit After Adjustments | 40 | 39 | 6 | 18 | 38 | 95 | 153 | 17 | 21 | 5 | 375 | 0 |
Adjusted Earnings Per Share | 69.3 | 67.2 | 10.8 | 31.3 | 65.9 | 165.5 | 266.3 | 30.2 | 36.2 | 1.1 | 653 | 64.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | -78% | -63% | -37% |
Operating Profit CAGR | 0% | -100% | -100% | -100% |
PAT CAGR | 37400% | 180% | 32% | 25% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -37% | -28% | -19% | 7% |
ROE Average | 69% | 24% | 21% | 18% |
ROCE Average | 63% | 22% | 22% | 23% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 178 | 207 | 209 | 220 | 374 | 509 | 615 | 486 | 588 | 537 | 557 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 30 | 10 | 0 | 0 | 70 | 0 | 0 | 14 | 0 |
Other Non-Current Liabilities | 95 | 94 | 108 | 117 | 27 | 36 | 40 | 216 | 216 | 215 | 179 |
Total Current Liabilities | 41 | 62 | 76 | 49 | 38 | 39 | 59 | 217 | 160 | 107 | 1 |
Total Liabilities | 314 | 363 | 423 | 396 | 440 | 585 | 784 | 919 | 964 | 873 | 737 |
Fixed Assets | 110 | 117 | 187 | 180 | 178 | 170 | 166 | 372 | 342 | 338 | 0 |
Other Non-Current Assets | 90 | 131 | 93 | 96 | 133 | 205 | 285 | 357 | 457 | 412 | 734 |
Total Current Assets | 113 | 115 | 143 | 120 | 129 | 210 | 333 | 190 | 164 | 123 | 3 |
Total Assets | 314 | 363 | 423 | 396 | 440 | 585 | 784 | 919 | 964 | 873 | 737 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 11 | 2 | 7 | 0 |
Cash Flow from Operating Activities | 41 | 28 | 21 | 22 | 59 | 94 | 148 | 16 | 61 | 9 | 1 |
Cash Flow from Investing Activities | -29 | -21 | -75 | 29 | -31 | -56 | -175 | -38 | -7 | 34 | 1 |
Cash Flow from Financing Activities | -12 | -7 | 54 | -51 | -28 | -35 | 35 | 14 | -49 | -49 | -3 |
Net Cash Inflow / Outflow | 0 | 0 | 0 | -0 | -0 | 3 | 8 | -9 | 4 | -6 | -0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 3 | 11 | 2 | 7 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 69.27 | 67.2 | 10.85 | 31.27 | 65.92 | 165.51 | 266.28 | 30.22 | 36.21 | 1.13 | 652.95 |
CEPS(Rs) | 88.41 | 84.14 | 23.4 | 46.85 | 81.45 | 181.5 | 282.35 | 49.76 | 66.66 | 1.13 | 652.95 |
DPS(Rs) | 15 | 15 | 5 | 10 | 34 | 65 | 65 | 12.5 | 12.5 | 5 | 1 |
Book NAV/Share(Rs) | 309.82 | 359.46 | 363.57 | 382.8 | 651.13 | 885.42 | 1070.28 | 846.45 | 1023.87 | 934.82 | 969.77 |
Core EBITDA Margin(%) | 28.07 | 23.35 | 9.97 | 13.77 | 26.64 | 46.08 | 56.32 | 13.12 | 19.91 | -1036.4 | -12.65 |
EBIT Margin(%) | 25.61 | 22.45 | 9.64 | 13.09 | 22.65 | 46.71 | 58.78 | 16.64 | 10.9 | 529.37 | 0 |
Pre Tax Margin(%) | 25.46 | 22.37 | 7.5 | 11.02 | 21.81 | 46.55 | 58.6 | 15.21 | 5.26 | 529.37 | 0 |
PAT Margin (%) | 16.77 | 14.8 | 2.85 | 6.9 | 14.48 | 30.28 | 38.12 | 9.11 | 9.28 | 225.37 | 0 |
Cash Profit Margin (%) | 21.4 | 18.53 | 6.14 | 10.34 | 17.9 | 33.21 | 40.41 | 15 | 17.07 | 225.37 | 0 |
ROA(%) | 13.96 | 11.42 | 1.59 | 4.39 | 9.07 | 18.57 | 22.37 | 2.04 | 2.21 | 0.07 | 46.61 |
ROE(%) | 24.4 | 20.08 | 3 | 8.38 | 12.75 | 21.54 | 27.23 | 3.15 | 3.87 | 0.12 | 68.57 |
ROCE(%) | 36.55 | 30.07 | 8.56 | 12.81 | 18.65 | 32.82 | 39.21 | 4.73 | 3.59 | 0.23 | 63.29 |
Receivable days | 43.08 | 44.87 | 58.09 | 48.92 | 45.93 | 50.21 | 38.11 | 60.16 | 45.62 | 0 | 1917.76 |
Inventory Days | 14.72 | 22.5 | 33.34 | 21.1 | 17.59 | 15.01 | 21.15 | 53.81 | 33.64 | 0 | 0 |
Payable days | 156.92 | 130.94 | 117.68 | 98.56 | 112.4 | 87.67 | 93.14 | 94.65 | 91.11 | 0 | 0 |
PER(x) | 6.46 | 6.41 | 51.76 | 17.74 | 14.87 | 14.12 | 10.58 | 38.83 | 60.58 | 1408.3 | 1.9 |
Price/Book(x) | 1.44 | 1.2 | 1.54 | 1.45 | 1.51 | 2.64 | 2.63 | 1.39 | 2.14 | 1.7 | 1.28 |
Dividend Yield(%) | 3.35 | 3.48 | 0.89 | 1.8 | 3.47 | 2.78 | 2.31 | 1.07 | 0.57 | 0.32 | 0.08 |
EV/Net Sales(x) | 1.21 | 1.07 | 2.01 | 1.49 | 2.47 | 4.38 | 4.19 | 4.37 | 6.43 | 3494.93 | 375.67 |
EV/Core EBITDA(x) | 3.58 | 3.73 | 13.95 | 7.93 | 7.56 | 8.65 | 6.87 | 19.39 | 23.99 | -337.22 | -2986.89 |
Net Sales Growth(%) | 37.82 | 10.49 | -16.3 | 18.97 | -0.53 | 31.53 | 31.4 | -52.52 | 12.5 | -99.87 | 558.14 |
EBIT Growth(%) | 54.71 | -3.61 | -64.01 | 61.61 | 73.84 | 147.63 | 60.84 | -86.55 | -22.94 | -93.78 | 0 |
PAT Growth(%) | 44.85 | -2.99 | -83.86 | 188.23 | 110.8 | 151.08 | 60.89 | -88.65 | 19.84 | -96.89 | 0 |
EPS Growth(%) | 44.85 | -2.99 | -83.86 | 188.23 | 110.8 | 151.08 | 60.89 | -88.65 | 19.84 | -96.89 | 0 |
Debt/Equity(x) | 0.01 | 0.02 | 0.35 | 0.14 | 0.03 | 0 | 0.13 | 0.33 | 0.21 | 0.17 | 0 |
Current Ratio(x) | 2.78 | 1.84 | 1.88 | 2.45 | 3.36 | 5.32 | 5.69 | 0.87 | 1.03 | 1.15 | 2.18 |
Quick Ratio(x) | 2.58 | 1.46 | 1.67 | 2.17 | 3.07 | 4.95 | 5.28 | 0.76 | 0.92 | 0.88 | 2.18 |
Interest Cover(x) | 175.08 | 270.65 | 4.5 | 6.33 | 26.81 | 290.04 | 322.89 | 11.59 | 1.93 | 0 | 0 |
Total Debt/Mcap(x) | 0 | 0.02 | 0.23 | 0.1 | 0.02 | 0 | 0.05 | 0.24 | 0.1 | 0.1 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 | 70.76 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.07 | 0 | 0 |
DII | 0.25 | 0.25 | 0.25 | 0.27 | 0.27 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Public | 28.99 | 28.99 | 28.99 | 28.97 | 28.97 | 29.23 | 29.23 | 29.16 | 29.23 | 29.23 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About